tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Florent Cespedes, 6 are a HOLD (37.5%), 6 are a BUY (37.5%), 4 are a SELL (25%).
Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 50% that have a potential upside of 17.22% achieved within 417 days. Previously, Florent Cespedes worked at JEFFERIES.
Florent Cespedes’s has documented 24 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 09-Sep-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 11/3/2020. The price target of $30.79 was fulfilled within 1 day with a profit of $0.83 (2.77%) receiving and performance score of 27.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 10-Sep-2026
$940
$-175.7 (-15.75%)
$850
Buy Since 24-Nov-2021
$1376
$260.3 (23.33%)
$1370
1 months 5 days ago
(07-Aug-2026)
12/14 (85.71%)
$190.29 (16.05%)
175
Buy Since 14-Apr-2023
$1330
$214.3 (19.21%)
$1280
1 months 6 days ago
(06-Aug-2026)
23/24 (95.83%)
$138.06 (11.58%)
139
Buy Since 27-Feb-2020
$1410
$294.3 (26.38%)
$1350
1 months 6 days ago
(06-Aug-2026)
21/23 (91.3%)
$218.06 (18.29%)
142
Buy Since 13-Oct-2017
$1600
$484.3 (43.41%)
$1500
1 months 28 days ago
(15-Jul-2026)
31/33 (93.94%)
$443.37 (38.33%)
222
What Year was the first public recommendation made by Florent Cespedes?
